Radiological imaging techniques, such as multiparametric magnetic resonance imaging (mpMRI), and nuclear medicine methods, notably skeletal scintigraphy and positron emission tomography (PET) utilizing 68Ga prostate-specific membrane antigen (PSMA) ligands, play pivotal roles in diagnosing the advanced stages of PC [5]. This evidence concerns the gene FOLH1 and pachyonychia congenita.